X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB VENUS REMEDIES UNICHEM LAB/
VENUS REMEDIES
 
P/E (TTM) x -67.3 -8.7 - View Chart
P/BV x 0.8 0.1 558.5% View Chart
Dividend Yield % 2.2 0.0 -  

Financials

 UNICHEM LAB   VENUS REMEDIES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
VENUS REMEDIES
Mar-17
UNICHEM LAB/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs382143 267.5%   
Low Rs23465 360.2%   
Sales per share (Unadj.) Rs116.3324.2 35.9%  
Earnings per share (Unadj.) Rs-18.96.4 -295.2%  
Cash flow per share (Unadj.) Rs-11.740.6 -28.9%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.0366.0 104.1%  
Shares outstanding (eoy) m70.3412.34 570.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.60.3 826.5%   
Avg P/E ratio x-16.316.2 -100.4%  
P/CF ratio (eoy) x-26.22.6 -1,024.7%  
Price / Book Value ratio x0.80.3 284.8%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6681,282 1,690.0%   
No. of employees `0002.30.9 252.5%   
Total wages/salary Rs m2,006251 799.4%   
Avg. sales/employee Rs Th3,587.84,430.1 81.0%   
Avg. wages/employee Rs Th880.0278.0 316.6%   
Avg. net profit/employee Rs Th-583.787.6 -666.4%   
INCOME DATA
Net Sales Rs m8,1804,000 204.5%  
Other income Rs m61023 2,687.7%   
Total revenues Rs m8,7904,023 218.5%   
Gross profit Rs m-1,320785 -168.2%  
Depreciation Rs m505422 119.8%   
Interest Rs m80344 23.3%   
Profit before tax Rs m-1,29542 -3,076.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33-37 -90.3%   
Profit after tax Rs m-1,33179 -1,682.6%  
Gross profit margin %-16.119.6 -82.3%  
Effective tax rate %-2.6-87.9 2.9%   
Net profit margin %-16.32.0 -822.8%  
BALANCE SHEET DATA
Current assets Rs m23,3182,606 894.7%   
Current liabilities Rs m4,6351,980 234.1%   
Net working cap to sales %228.415.6 1,459.7%  
Current ratio x5.01.3 382.2%  
Inventory Days Days122128 94.9%  
Debtors Days Days12143 281.5%  
Net fixed assets Rs m8,1635,353 152.5%   
Share capital Rs m141123 114.0%   
"Free" reserves Rs m26,6604,393 606.9%   
Net worth Rs m26,8014,516 593.5%   
Long term debt Rs m31,618 0.2%   
Total assets Rs m31,8908,291 384.6%  
Interest coverage x-15.21.1 -1,351.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.30.5 53.2%   
Return on assets %-3.95.1 -76.9%  
Return on equity %-5.01.8 -283.5%  
Return on capital %-4.56.3 -72.2%  
Exports to sales %00-   
Imports to sales %018.4 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA736 0.0%   
Fx inflow Rs m4,3560-   
Fx outflow Rs m0736 0.0%   
Net fx Rs m4,356-736 -591.7%   
CASH FLOW
From Operations Rs m-1,123997 -112.7%  
From Investments Rs m16,487-461 -3,574.0%  
From Financial Activity Rs m-8,811-571 1,543.1%  
Net Cashflow Rs m6,552-35 -18,666.7%  

Share Holding

Indian Promoters % 50.1 32.9 152.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.2 8,388.9%  
FIIs % 3.0 0.6 517.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 66.4 47.7%  
Shareholders   20,176 20,121 100.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   TORRENT PHARMA  NATCO PHARMA  BIOCON LTD  PFIZER  ALKEM LABORATORIES  

Compare UNICHEM LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 17, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS